Nasivin (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nasivin, is an alpha‑adrenergic agonist presented as a 0.05% (w/v) nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Nasivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline Hydrochloride is used as a topical nasal decongestant to reduce swelling of the nasal mucosa.

- Common cold: provides rapid relief of nasal congestion by shrinking swollen nasal passages. - Sinusitis: helps alleviate congestion associated with sinus inflammation, improving airflow. - Allergic rhinitis: reduces nasal blockage caused by allergic reactions, supporting easier breathing.

Oxymetazoline Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Headache - Altered taste sensation - Mild epistaxis (nosebleed)

Serious or Rare Side Effects: - Rebound nasal congestion (rhinitis medicamentosa) with prolonged use - Hypertension or elevated blood pressure - Cardiac arrhythmias - Severe nasal ulceration or tissue necrosis - Allergic reactions including rash, itching, or anaphylaxis

When using Nasivin, consider the following safety measures.

- Age restriction: not recommended for children under 6 years without medical advice. - Duration of use: limit to three consecutive days to avoid rebound congestion. - Cardiovascular conditions: use with caution in patients with hypertension or heart disease. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Drug interactions: avoid concurrent use with monoamine oxidase inhibitors or other vasoconstrictors. - Store at room temperature: keep below 25 °C, protect from moisture and direct sunlight.

Oxymetazoline Hydrochloride can interact with several drug classes; awareness helps minimize risk.

Major Interactions (Avoid): - MAO inhibitors: may potentiate hypertensive effects. - Other nasal decongestants: risk of excessive vasoconstriction. - Sympathomimetic agents (e.g., phenylephrine): additive cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may reduce blood‑pressure control efficacy. - Tricyclic antidepressants: possible increase in blood pressure. - Beta‑blockers: monitor for bradycardia or hypertension.